REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S (Colombia)

Main Activities: Other Ambulatory Health Care Services
Full name: Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S is a company based in Colombia, with its head office in Valledupar. It operates in the Other Ambulatory Health Care Services industry. Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S was incorporated on May 26, 2014. The total number of employees is currently 10 (2017). From the latest financial highlights, Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S reported a net sales revenue increase of 34.47% in 2023. Its’ total assets recorded a growth of 33.69%. The net profit margin of Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S increased by 9.58% in 2023.

Headquarters
Cl 6C 13B 70
Valledupar; Cesar;

Contact Details: Purchase the Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S report to view the information.
Outstanding Shares:
Purchase the Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S report to view the information.
Incorporation Date:
May 26, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Neurodesarrollo La Esperanza Astrid Maury S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
34.47%
Total operating revenue
34.47%
Operating profit (EBIT)
84.59%
EBITDA
78.62%
Net Profit (Loss) for the Period
285.37%
Total assets
33.69%
Total equity
57.99%
Operating Profit Margin (ROS)
7.73%
Net Profit Margin
9.58%
Return on Equity (ROE)
21.66%
Debt to Equity Ratio
-16.72%
Quick Ratio
0.48%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?